Together, these data suggest that LRRC75A-AS1 promotes BC tumor growth and metastasis in vivo by acting as a ceRNA for miR-489-3p, thereby upregulating ARD1 expression and promoting EMT. This evidence concerns the gene LRRC75A and breast cancer.